Nine new Griffith-led ARC Discovery Projects awarded $3,622,738.
A national team of experts will advance an innovative biopolymer particle-based platform technology to develop vaccine candidates to protect against biowarfare threats.
Griffith University researchers are on the brink of a technological breakthrough in vaccine development with a possible new vaccine modality.
Griffith University researchers have developed a potential vaccine for a pathogen causing severe infection in immunocompromised people.
Researchers have received grants worth over $6.96 million from the Australian Research Council.
Griffith University scientists have won a worldwide search for new ways to recover lifesaving antibodies from human plasma.
Scientists develop low-cost platform which could detect early cancer
Scientists at Griffith University are moving towards animal trials in testing a vaccine candidate for COVID-19
Griffith University and Queensland-based Luina Bio has announced they have entered into a Memorandum of Understanding (MoU) targeting the development...
Griffith University has been awarded $3,376,073 for ARC Discovery and Linkage Projects.
